- Home
- AKRO vs INTA Comparison
AKRO vs INTA Comparison
Compare AKRO & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- INTA
- Stock Information
- Founded
- AKRO 2017
- INTA 2000
- Country
- AKRO United States
- INTA United States
- Employees
- AKRO N/A
- INTA N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- INTA Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- INTA Technology
- Exchange
- AKRO Nasdaq
- INTA Nasdaq
- Market Cap
- AKRO 3.9B
- INTA 4.3B
- IPO Year
- AKRO 2019
- INTA 2021
- Fundamental
- Price
- AKRO $50.56
- INTA $41.64
- Analyst Decision
- AKRO Strong Buy
- INTA Buy
- Analyst Count
- AKRO 6
- INTA 10
- Target Price
- AKRO $82.50
- INTA $61.78
- AVG Volume (30 Days)
- AKRO 1.1M
- INTA 795.4K
- Earning Date
- AKRO 08-08-2025
- INTA 08-12-2025
- Dividend Yield
- AKRO N/A
- INTA N/A
- EPS Growth
- AKRO N/A
- INTA N/A
- EPS
- AKRO N/A
- INTA N/A
- Revenue
- AKRO N/A
- INTA $483,457,000.00
- Revenue This Year
- AKRO N/A
- INTA $18.76
- Revenue Next Year
- AKRO N/A
- INTA $14.17
- P/E Ratio
- AKRO N/A
- INTA N/A
- Revenue Growth
- AKRO N/A
- INTA 17.70
- 52 Week Low
- AKRO $21.34
- INTA $31.08
- 52 Week High
- AKRO $58.40
- INTA $77.74
- Technical
- Relative Strength Index (RSI)
- AKRO 44.48
- INTA 23.62
- Support Level
- AKRO $50.60
- INTA $42.09
- Resistance Level
- AKRO $52.55
- INTA $42.92
- Average True Range (ATR)
- AKRO 1.83
- INTA 1.46
- MACD
- AKRO -0.35
- INTA -0.07
- Stochastic Oscillator
- AKRO 17.66
- INTA 5.63
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.